Take Action. Demand Transparency.


 

Tell the SEC: Require Corporations to Disclose Political Spending

Big Business is secretly funneling millions of dollars into our political system.
Take action to protect democracy!

 

Derail the Trans-Pacific Partnership

TPP negotiations continue with the public locked out and details held in tight secrecy.
Urge U.S. Trade representative Ron Kirk to release the draft texts.

 

Tell Congress to Pass the DISCLOSE Act

The American public should know who is funding elections.
Email your members of Congress and encourage them to support the DISCLOSE Act (H.R. 4010).

Transparency in Health Safety and Product Safety


Health Safety


Public Citizen has worked for more than four decades to make sure there is clear transparency in the American health care system.

Patient Safety


The first goal in good medicine is keeping the patient safe. That means having reasonable access to quality and unbiased information about all aspects of their health care.

Physician Accountability


Public Citizen works toward enhanced accountability in the medical field by physician accountability — analyzing trends in state disciplinary actions across the U.S. and pushing for greater disclosure of disciplinary actions taken against doctors and other health care workers.

Public Citizen report: Incomplete information in as many as 50,000 reports provided to the National Practitioner Data Bank, which serves as a national clearinghouse of transgressions by physicians and other health care providers that are critical to employment and credentialing decisions.

Unethical Trials


The SUPPORT study: A trial that involved randomly assigning premature infants to one of two experimental groups. Researchers tried to keep blood oxygen levels in a high range for one group and a low range for the other. Parents were not informed that this experiment involved substantial risks for their babies, including increased risk of blindness, brain injury and death, depending on which group the babies were in.

  • Press Advisory: Press conference to highlight the need for HHS to strengthen the ethical standards by which human experiments are conducted.
  • In the wake of controversy of the SUPPORT study, HHS hosts a meeting to look at what risks should be disclosed to participants in clinical trials.
  • Letter to HHS: NIH should not censor one of its experts just because he might criticize ethical lapses in an increasingly high-profile study carried out on premature babies.
  • Release: The federal government has taken an important step toward addressing a highly unethical trial involving premature babies but still is leaving infants and other subjects at risk by permitting current similar trials to continue.
  • Letter to the HHS secretary asking for a personally apologize to the parents of the HHS-funded experiment that exposed babies to risk of death and blindness without informing the parents.

Improved Patient Drug Information Program


Public Citizen petitioned the FDA to ban the distribution of dangerously misleading prescription drug information to the public by pharmacists arguing that drugs were misbranded when dispensed with inaccurate or misleading information. Read the comments, lawsuit and settlement that lead to an open discussion on the Improved Patient Drug Program:


FDA Labeling


Public Citizen petitions FDA for a black box warning on testosterone products to warn patients of cardiovascular risks.

Statement of Dr. Sidney Wolfe: FDA proposal to revise drug labeling regulations is welcome news and will improve drug safety.

Public Citizen report highlights the need to allow generic drug manufacturers to update labeling as they learn of new risks to protect patient safety.

Freedom of Information


Public Citizen petitioned the FDA to stop its longstanding practice of redacting portions of documents released to Freedom of Information Act (FOIA) requesters without giving requesters an immediate right to appeal within the agency.

Conflict of Interest


It's often hard to tell when drug companies pay doctors lavish speaking fees and when medical journal authors do work for drug companies. But these payments and relationships have the potential to influence what drugs doctors prescribe.

Clinical Trials Design


A policy study of clinical trial registries and results database as evidence exists that pharmaceutical companies have suppressed unfavorable data.

Drug Promotion


Read about how Public Citizen went to court to enforce a Vermont law requiring drug companies to report the value and nature of gifts they give doctors and hospitals to the Vermont Attorney General.

Read our testimony before the Senate Special Committee on Aging in support of state laws requiring the disclosure of pharmaceutical company payments to physicians.

Congressional testimony on state laws requiring disclosure of pharmaceutical company payments to physicians.

Medical Safety vs. Corporate Profits


Public Citizen and other groups sent a letter to lawmakers warning that a provision in the 2012 Food and Drug Administration Reform Act would block public access to potentially important health and safety information should be removed or substantially narrowed.

Read our 2002 comments on disclosure of conflicts of interest for participants in FDA advisory committee.

Read more about our work to protect patients by uncovering these conflicts of interest.

Drug Manufacturing and Approval Process


Keeping Dangerous Drugs Off the Market


Read our 2012 letter to the FDA addressing failures to disclose new drug application approval packages in a timely manner.

Our 2010 recommendations to the FDA on how the agency can alert the public to dangers and promote scientific innovation at the same time.

Our 2009 testimony before the FDA Transparency Task Force encouraging greater transparency.

When the FDA released documents related to its evaluation of the safety and effectiveness of the drug Bextra, it withheld key portions. Public Citizen sued the FDA and won.

Read our 2001 comments on disclosure of information on investigational products.

Read our 2001 comments on the FDA’s proposed changes to disclosure of information from FDA Advisory Committee.

Public Citizen took the FDA to court to try to get information concerning pre-clinical and clinical studies for prescription drugs, in which clinical trials were discontinued because of death or serious injury.

In a letter Public Citizen called for a congressional investigation to find out who at the FDA knew about the status of a tamper-resistant hydrocodone product that had already been developed, when the FDA approved a dangerous, high-dose, non-tamper-resistant opioid known as Zohydro ER.

Compounding Drug Manufacturing


  • Read Public Citizen comments submitted to the Health Subcommittee of the House Energy and Commerce Committee regarding compounding pharmacy legislation.
  • Public Citizen to Congress: Proposed compounding pharmacy legislation would be a major step backward for U.S. drug safety, efficacy and accurate labeling.

Off-Label Use of Drugs


Public Citizen went to court to get information regarding records of off-label, unapproved uses of previously approved drugs and biologics.

Transparency in Product Safety

Public Citizen works to make sure Americans are protected from unsafe products and fights for clearer transparency regarding consumer product safety.

Consumer Product Safety Commission


Imagine a database accessible by anyone in the country and that contains a treasure trove of information about dangerous products that have harmed people. Such a database exists — it was created as part of the Consumer Product Safety Improvement Act of 2008. Public Citizen pushed hard to ensure that consumers can warn others about dangers — and that the government and manufacturers respond.


Stalled Rulemaking Regarding Consumer Protections


Release: Calling out the Obama administration for stalling a crucial auto safety rule in an obscure White House office for a year and a half, where the public couldn’t see what was going on.

Public Citizen report: Public pays price as eight key food safety, financial, worker safety and environmental rules held up.

Company Doe v. Public Citizen


A company sued to keep a complaint about one of its products out of a database created by the Consumer Product Safety Commission (CPSC) and persuaded a district court judge to adjudicate the matter in secret, sealing documents pertaining to the case and permitting the company to use the pseudonym “Company Doe.” Public Citizen objected to the seal.

  • Advisory: Public Has Right to Know Identity of ‘Company Doe,’ Access Court Records in Consumer Product Database Case, Public Citizen to Tell Federal Appellate Court.
  • Release: Fourth Circuit: Injury to Corporate Reputation Not Enough to Justify Sealing Court Case.

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.